Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

Blood Cancer J. 2020 Jan 30;10(1):11. doi: 10.1038/s41408-020-0279-4.

¹ Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org.
³ Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. hultcram@mskcc.org.
⁴ Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ University of Milan, Department of Oncology and Onco-Hematology, Milan, Italy.
⁸ Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology and Hematology, Milan, Italy.
⁹ Hematopathology Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁰ Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹¹ Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. zhangy1@mskcc.org.
¹² Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. landgrec@mskcc.org.

^# Contributed equally.

Abstract

A correction to this paper has been published and can be accessed via a link at the top of the paper.